Showing results (11-20 of 2,957) with videos related to

Sort By:
Pageof 296
Molecular Medicine (Cambridge, Mass.)|June 20, 2022
Central nervous system effects of 5-HT7 receptors: a potential target for neurodegenerative diseasesAlejandro Quintero-Villegas, Sergio Iván Valdés-Ferrer
Molecular Medicine (Cambridge, Mass.)|January 12, 2023
Evaluation of two laboratory model methods for diarrheal irritable bowel syndromeQian Chen, Hua Zhang, Chang-Yue Sun, et al.
Molecular Medicine (Cambridge, Mass.)|January 16, 2023
Placental DNA methylation profile as predicting marker for autism spectrum disorder (ASD)Amin Ravaei, Marco Emanuele, Giovanni Nazzaro, et al.
Molecular Medicine (Cambridge, Mass.)|December 29, 2022
OLMALINC/OCT4/BMP2 axis enhances osteogenic-like phenotype of renal interstitial fibroblasts to participate in Randall's plaque formationZewu Zhu, Fang Huang, Yingcheng Jiang, et al.
Molecular Medicine (Cambridge, Mass.)|June 6, 2022
α7 nicotinic acetylcholine receptor agonist GTS-21 attenuates DSS-induced intestinal colitis by improving intestinal mucosal barrier functionZiping Ye, Yunjuan Zhu, Nana Tang, et al.
Molecular Medicine (Cambridge, Mass.)|June 28, 2022
FGF1 alleviates LPS-induced acute lung injury via suppression of inflammation and oxidative stressQhaweni Dhlamini, Wei Wang, Guifeng Feng, et al.
Molecular Medicine (Cambridge, Mass.)|June 11, 2022
Evaluation of serum tRF-23-Q99P9P9NDD as a potential biomarker for the clinical diagnosis of gastric cancerYu Zhang, Xinliang Gu, Xinyue Qin, et al.
Molecular Medicine (Cambridge, Mass.)|November 26, 2022
Modular networks and genomic variation during progression from stable angina pectoris through ischemic cardiomyopathy to chronic heart failureLin Chen, Ya-Nan Yu, Jun Liu, et al.
Molecular Medicine (Cambridge, Mass.)|May 5, 2022
Resveratrol ameliorates liver fibrosis induced by nonpathogenic Staphylococcus in BALB/c mice through inhibiting its growthZhiqin Li, Jianxia Dong, Meng Wang, et al.
Molecular Medicine (Cambridge, Mass.)|September 17, 2010
High-mobility group box-1 protein (HMGB1) is increased in antineutrophilic cytoplasmatic antibody (ANCA)-associated vasculitis with renal manifestationsAnnette Bruchfeld, Mårten Wendt, Johan Bratt, et al.
Pageof 296